Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 31, 2023Nature AgingOpen Access

A two-step workflow based on plasma p-tau217 to screen for amyloid β positivity with further confirmatory testing only in uncertain cases

View Full Paper
Ask AI
Bookmark
Share

Authors

WBWagner S. BrumNCNicholas CullenSJShorena Janelidze

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Brum et al. (2023) studied this question.

synapsesocial.com/papers/69d72f245dca7d66cbbef2efhttps://doi.org/10.1038/s43587-023-00471-5
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Assessment of a Plasma Amyloid Probability Score to Estimate Amyloid Positron Emission Tomography Findings Among Adults With Cognitive Impairment2022 · 130 citations
  2. 2Prevalence of the apolipoprotein E ε4 allele in amyloid β positive subjects across the spectrum of Alzheimer's disease2018 · 87 citations
  3. 3Brief Cognitive Tests Used in Primary Care Cannot Accurately Differentiate Mild Cognitive Impairment from Subjective Cognitive Decline2020 · 54 citations
  4. 4Associations between tau, Aβ, and cortical thickness with cognition in Alzheimer disease2019 · 335 citations
  5. 5The Alzheimer's Association appropriate use recommendations for blood biomarkers in Alzheimer's disease2022 · 624 citations